Onychomycosis

40%

of the population between 40 and 60 years of age is affected

Onychomycosis represents between 18% and

40%

of all onychopathies

It is more common in

women

than in men

Onychomycosis is an infection of the nails caused by fungi that feed on keratin, the protein that makes up the majority of the nail surface. The toenails are most susceptible because they are exposed to moist, dark, warm environments more frequently than the fingernails. This is considered the ideal environment for fungal growth.

Treating onychomycosis is a challenge because the fungal infection becomes embedded in the nail. It may take a year or more to fully clear because the new nail growth (treated) must grow out and completely substitute the affected part. Onychomycosis treatment depends on the clinical type of fungus, the number of nails affected and the severity of the infection.

LASER treatment of onychomycosis offers several advantages compared to conventional treatment: there is no risk of internal organ toxicity, no uncomfortable side effects, and no scientific reports of fungal resistance to the LASER. This means that even if treatment is suspended, the LASER’s destructive impact on the fungus remains effective. In case of recurrence, the LASER can be used repeatedly with the same results.

Onychomycoses are the most common diseases of the nail, representing between 18% and 40% of all onychopathies.

Dermatophyte infection affects approximately 40% of the adult population worldwide (40 to 60 years old) and is more common in women than in men.

In England, onychomycosis affects between 3% and 8% of the population. In Ireland, 15% to 20% of adults between 40 and 60 years of age suffer from the disease – with higher prevalence among the elderly.

In the United States, it is estimated that the disease affects between 2% and 13% of the population. Onychomycosis affects approximately 1 in 5 people between 40 and 60 years of age.

See the results

PRODUCTS RELATED TO THIS TREATMENT